The pharmaceutical landscape is witnessing a development with the arrival of GLP-1 transdermal systems . These cutting-edge formulations offer a possible alternative to providing glucagon-like peptide-1 https://shaunabjck232256.aioblogs.com/93656560/glp-1-patches-a-new-way-to-control-blood-sugar